Strategic funding SDRI operates with a revenue range of 25M to 50M and maintains a strong research focus, suggesting opportunities to offer high-value partnership programs, sponsored studies, and philanthropy-aligned initiatives that align with diabetes innovation.

Clinical innovation With a world-class reputation in artificial pancreas development and diabetes in pregnancy, there is potential to propose collaborations on pilot trials, IP licensing, and joint development of smart device ecosystems and clinical decision support tools.

Leadership expansion Recent hires in executive science and medical leadership along with new board members indicate a growth-oriented governance and prioritization of research scale, signaling readiness for large-scale collaborations, more formalized partnerships, and multi-site studies.

Community outreach Launch of a free walk-in screening clinic demonstrates commitment to community engagement and early-detection initiatives, presenting sales avenues for education programs, screening analytics solutions, and data collection partnerships.

Technology stack Existing tech footprint includes WordPress, Google Cloud, and Microsoft 365, which may ease integration for digital health platforms, data collaboration tools, donor management, and scalable patient education experiences in partnership deals.